Market cap
₹1,911 Cr
Revenue (TTM)
₹193 Cr
P/E Ratio
70.3
P/B Ratio
11
Div. Yield
0.1 %
Quality Score
7/10
Growth Score
7/10
Valuation Score
2/10
Momentum Score
7/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹27 Cr
-
ROE
12.7 %
-
ROCE
17 %
-
Industry P/E
24.16
-
EV/EBITDA
50.2
-
Debt to Equity
0
-
Book Value
₹42.2
-
EPS
₹25.4
-
Face value
2
-
Shares outstanding
41,318,500
10 Years Aggregate
CFO
₹121.98 Cr
EBITDA
₹205.33 Cr
Net Profit
₹134.72 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Titan Bio-Tech
| 119.5 | -4.0 | 80.3 | 408.4 | 111.0 | 50.6 | 53.1 |
|
BSE Commodities
| 10.1 | 4.7 | 5.0 | 15.7 | 18.7 | 11.7 | 16.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Titan Bio-Tech
| 38.1 | 78.0 | 37.7 | 0.4 | 95.1 | 280.6 | -18.6 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Commodities
| 12.5 | 8.1 | 17.5 | 1.2 | 61.5 | 26.1 | -4.6 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Titan Bio-Tech
|
462.6 | 1,911.4 | 192.5 | 24.7 | 15.1 | 17 | 70.3 | 11.0 |
| 1,730.5 | 8,832.6 | 1,535.9 | 180.0 | 13.9 | 12.1 | 49.1 | 5.8 | |
| 3,491.4 | 15,137.2 | 15,226.8 | 420.1 | 3.4 | 10.7 | 36 | 3.8 | |
| 1,448.7 | 18,335.1 | 11,162.0 | 877.2 | 12.4 | 13.7 | 21 | 2.8 | |
| 1,245.4 | 5,357.9 | 2,527.2 | 332.0 | 15.8 | 16.1 | 16.1 | 2.4 | |
| 1,821.9 | 6,474.6 | 5,248.3 | 267.4 | 6.7 | 10.5 | 24.2 | 2.4 | |
| 2,639.3 | 8,469.0 | 15,929.8 | 1,844.4 | 16.6 | 12.4 | 9.1 | 1.1 | |
| 5,528.1 | 7,472.3 | 1,886.6 | 168.0 | 11.4 | 16.6 | 44.5 | 5.6 | |
| 7,396.0 | 37,897.2 | 3,313.9 | 663.6 | 28.1 | 17.7 | 57.1 | 9.5 | |
| 783.9 | 19,974.2 | 14,584.0 | -1,882.0 | 4.1 | 0.6 | -- | 0.9 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Titan Bio-Tech
Titan Biotech Limited manufactures and sells biological products in India. The company offers food ingredients, including hydrolyzed vegetable protein, yeast extract powder, calcium propionate powder, potassium sorbate, and calcium lactate; collagen... and protein products, such as specter whey protein, collagen peptides, brown rice protein, fish collagen, pea protein isolate, chicken protein isolate, soya protein isolate, milk protein, and protein hydrolysate; and nutraceutical and pharmaceutical products comprising sodium caseinate, chondroitin sulfate, hyaluronic acid, methyl sulphonyl methane, chelated minerals, peptone, OX bile extract, cholic acid, cerebroprotein hydrolysate, methyl sulphonyl methane, iron protein succinylate, medicinal yeast, and brewer yeast protein, as well as liver, meat, malt, and yeast extracts. In addition, it provides products in the areas of animal nutrition, including binding agents, chelates minerals, mold inhibitors, proteins, and yeasts. The company's products are used in the field of pharmaceuticals, nutraceuticals, food and beverages, biotechnology and fermentation, cosmetics, veterinary and animal feed, agriculture, microbiology culture media, plant tissue culture media, etc. The company also exports its products. Titan Biotech Limited was incorporated in 1992 and is based in New Delhi, India. Read more
-
Incorporated
1992
-
Chairman
Rohit Jain
-
Managing Director
Suresh Chand Singla
-
Headquarters
Bhiwadi, Rajasthan
-
Website
Annual Reports
FAQs for Titan Bio-Tech
What is the current share price of Titan Bio-Tech Ltd Today?
The share price of Titan Bio-Tech Ltd is ₹462.60 (BSE) as of 26-May-2026 IST. Titan Bio-Tech Ltd has given a return of 111.05% in the last 3 years.
What is the current PB & PE ratio of Titan Bio-Tech Ltd?
The P/E ratio of Titan Bio-Tech Ltd is 70.26 times as on 26-May-2026, a 191 premium to its peers’ median range of 24.16 times.
The P/B ratio of Titan Bio-Tech Ltd is 10.97 times as on 26-May-2026, a 590 premium to its peers’ median range of 1.59 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
16.18
|
2.27
|
|
2024
|
17.56
|
3.27
|
|
2023
|
6.55
|
1.48
|
|
2022
|
9.99
|
2.51
|
|
2021
|
5.05
|
2.23
|
What is the 52 Week High and Low of Titan Bio-Tech Ltd?
The 52-week high and low of Titan Bio-Tech Ltd are Rs 555.65 and Rs 74.73 as of 26-May-2026.
What is the market cap of Titan Bio-Tech Ltd?
Titan Bio-Tech Ltd has a market capitalisation of ₹ 1,911 Cr as on 26-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Titan Bio-Tech Ltd?
Before investing in Titan Bio-Tech Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.